Progestins for symptomatic endometriosis: a critical analysis of the evidence. (Q39453269)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9314903%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Progestins for symptomatic endometriosis: a critical analysis of the evidence (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9314903%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9314903%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

I Cortesi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9314903%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

P G Crosignani

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9314903%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 September 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9314903%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

published in

Fertility and Sterility

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9314903%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9314903%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9314903%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

393-401

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9314903%20AND%20SRC:MED&resulttype=core&format=json

Endometriosis and pelvic pain: relation to disease stage and localization

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

Laparoscopy versus laparotomy in conservative surgical treatment for severe endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

Treatment of endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

The morphologic effect of short-term medical therapy of endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

Very low dose danazol for relief of endometriosis-associated pelvic pain: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis after conservative surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

Danazol and medroxyprogesterone acetate inefficacious in the treatment of infertility in endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

Lipid metabolism during treatment of endometriosis with the progestin dienogest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

Long-term use of the low dose LHRH analogue combined with monthly medroxy-progesterone administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

The Effect of Medroxyprogesterone Acetate on Endometriosis in the Human Female

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

Comparison of different treatment modalities of endometriosis in infertile women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

Dydrogesterone and endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

Treatment of endometriosis: a study of medical management.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

A randomized, double-blind, placebo-controlled study of luteal phase dydrogesterone (Duphaston) in women with minimal to mild endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

Revised American Fertility Society classification of endometriosis: 1985

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

Meta-analyses of randomized controlled trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

A quantitative overview of controlled trials in endometriosis-associated infertility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

Medical treatment of mild endometriosis in infertile women: analysis of a failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

A skeleton in the closet? Bone health and therapy for endometriosis revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

Medroxyprogesterone acetate supplementation diminishes the hypoestrogenic side effects of gonadotropin-releasing hormone agonist without changing its efficacy in endometriosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

Histologic study of ovarian endometriosis after hormonal therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Treatment of endometriosis with estrogen-progestin combination and progestogens alone

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Comparison of cyproterone acetate and danazol in the treatment of pelvic pain associated with endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900193-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0015-0282(97)00193-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9314903%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference